Indraprastha Medical 미래 성장

Future 기준 확인 3/6

Indraprastha Medical (는) 각각 연간 13.4% 및 14.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 13.3% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 23.7% 로 예상됩니다.

주요 정보

13.4%

수익 성장률

13.3%

EPS 성장률

Healthcare 수익 성장	27.3%
매출 성장률	14.3%
향후 자기자본 수익률	23.7%
애널리스트 커버리지	Low
마지막 업데이트	21 Jan 2025

최근 미래 성장 업데이트

업데이트 없음

Recent updates

The Trend Of High Returns At Indraprastha Medical (NSE:INDRAMEDCO) Has Us Very Interested

Dec 03

Calculating The Fair Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Oct 14

We Take A Look At Why Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Is Well Earned

Sep 18

Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year

Aug 30

Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year

Aug 11

Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Soars 34% But It's A Story Of Risk Vs Reward

Aug 08

Investors Should Be Encouraged By Indraprastha Medical's (NSE:INDRAMEDCO) Returns On Capital

Jun 12

Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Shares Fly 42% But Investors Aren't Buying For Growth

Apr 06

Why Investors Shouldn't Be Surprised By Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) Low P/E

Feb 01

Why The 29% Return On Capital At Indraprastha Medical (NSE:INDRAMEDCO) Should Have Your Attention

Nov 03

We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair

Sep 15

Indraprastha Medical's (NSE:INDRAMEDCO) Dividend Will Be Increased To ₹3.00

Sep 10

Indraprastha Medical's (NSE:INDRAMEDCO) Upcoming Dividend Will Be Larger Than Last Year's

Aug 27

Indraprastha Medical (NSE:INDRAMEDCO) Is Paying Out A Larger Dividend Than Last Year

Aug 08

Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)

Jul 31

Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation

Jan 21

We Think Indraprastha Medical's (NSE:INDRAMEDCO) Profit Is Only A Baseline For What They Can Achieve

Nov 12

Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Nov 02

Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)

May 12

Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Jun 10

Introducing Indraprastha Medical (NSE:INDRAMEDCO), A Stock That Climbed 24% In The Last Year

Feb 21

수익 및 매출 성장 예측

NSEI:INDRAMEDCO - 애널리스트의 미래 추정치 및 과거 재무 데이터 (INR Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
3/31/2027	18,516	2,066	-446	3,054	1
3/31/2026	15,130	1,841	14	2,314	1
3/31/2025	13,421	1,612	881	1,631	1
9/30/2024	13,189	1,478	1,079	1,620	N/A
6/30/2024	12,861	1,382	N/A	N/A	N/A
3/31/2024	12,447	1,240	1,308	2,002	N/A
12/31/2023	12,040	1,126	N/A	N/A	N/A
9/30/2023	11,745	1,041	447	1,084	N/A
6/30/2023	11,419	964	N/A	N/A	N/A
3/31/2023	10,987	862	999	1,445	N/A
12/31/2022	10,411	815	N/A	N/A	N/A
9/30/2022	10,000	765	1,133	1,432	N/A
6/30/2022	9,486	635	N/A	N/A	N/A
3/31/2022	8,882	586	648	943	N/A
12/31/2021	8,705	585	N/A	N/A	N/A
9/30/2021	8,139	546	726	974	N/A
6/30/2021	7,221	430	N/A	N/A	N/A
3/31/2021	6,134	23	59	268	N/A
12/31/2020	6,158	-63	N/A	N/A	N/A
9/30/2020	6,462	-76	417	632	N/A
6/30/2020	7,213	99	N/A	N/A	N/A
3/31/2020	8,308	436	455	865	N/A
12/31/2019	8,307	443	N/A	N/A	N/A
9/30/2019	8,185	407	N/A	N/A	N/A
6/30/2019	8,025	305	N/A	N/A	N/A
3/31/2019	7,882	284	581	752	N/A
12/31/2018	7,734	269	N/A	N/A	N/A
9/30/2018	7,610	253	N/A	N/A	N/A
6/30/2018	7,527	228	N/A	N/A	N/A
3/31/2018	7,527	211	N/A	477	N/A
12/31/2017	7,471	202	N/A	N/A	N/A
9/30/2017	7,537	207	N/A	N/A	N/A
6/30/2017	7,564	228	N/A	N/A	N/A
3/31/2017	7,657	262	N/A	276	N/A
12/31/2016	7,660	304	N/A	N/A	N/A
9/30/2016	7,635	283	N/A	N/A	N/A
6/30/2016	7,640	296	N/A	N/A	N/A
3/31/2016	7,554	244	N/A	623	N/A
12/31/2015	7,472	303	N/A	N/A	N/A
9/30/2015	7,340	323	N/A	N/A	N/A
6/30/2015	7,226	321	N/A	N/A	N/A
3/31/2015	7,145	325	N/A	643	N/A
12/31/2014	7,016	321	N/A	N/A	N/A
9/30/2014	6,949	331	N/A	N/A	N/A
6/30/2014	6,897	342	N/A	N/A	N/A
3/31/2014	6,776	354	N/A	581	N/A

애널리스트 미래 성장 예측

수입 대 저축률: INDRAMEDCO 의 연간 예상 수익 증가율( 13.4% )이 saving rate( 6.7% 보다 높습니다. ).

수익 vs 시장: INDRAMEDCO 의 연간 수익( 13.4% ) Indian 시장( 18% 보다 느리게 성장할 것으로 예상됩니다. 18% 연간).

고성장 수익: INDRAMEDCO 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: INDRAMEDCO 의 수익(연간 14.3% ) Indian 시장( 10.6% 보다 빠르게 성장할 것으로 예상됩니다. 10.6% 연간).

고성장 수익: INDRAMEDCO 의 수익(연간 14.3% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: INDRAMEDCO 의 자본 수익률은 3년 내에 최고 수준이 될 것으로 예상됩니다. ( 23.7 %)

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2025/01/22 16:00
장 마감 주가	2025/01/22 00:00
수익	2024/09/30
연간 수익	2024/03/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

Indraprastha Medical Corporation Limited 3 애널리스트 중 1 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Himanshu Binani	Anand Rathi Shares and Stock Brokers Limited
Ranjit Kapadia	Centrum Broking Limited
Kameswari V. S. Chavali	FirstCall Research

Indraprastha Medical 미래 성장

Future 기준 확인 3/6

주요 정보

최근 미래 성장 업데이트

Recent updates

Indraprastha Medical Corporation Limited to Report Q3, 2025 Results on Feb 03, 2025

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Investor sentiment improves as stock rises 15%

The Trend Of High Returns At Indraprastha Medical (NSE:INDRAMEDCO) Has Us Very Interested

Second quarter 2025 earnings released: EPS: ₹4.63 (vs ₹3.58 in 2Q 2024)

Calculating The Fair Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Indraprastha Medical Corporation Limited Approves the Cash Dividend for the Financial Year Ended March 31, 2024

We Take A Look At Why Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Is Well Earned

Investor sentiment improves as stock rises 19%

Now 22% overvalued after recent price rise

Upcoming dividend of ₹4.50 per share

Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year

Investor sentiment improves as stock rises 16%

Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year

Dividend increased to ₹4.50

Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Soars 34% But It's A Story Of Risk Vs Reward

Indraprastha Medical Corporation Limited, Annual General Meeting, Sep 24, 2024

First quarter 2025 earnings released: EPS: ₹4.88 (vs ₹3.33 in 1Q 2024)

Indraprastha Medical Corporation Limited to Report Q1, 2025 Results on Aug 05, 2024

Investors Should Be Encouraged By Indraprastha Medical's (NSE:INDRAMEDCO) Returns On Capital

New major risk - Share price stability

Full year 2024 earnings released: EPS: ₹13.52 (vs ₹9.40 in FY 2023)

Indraprastha Medical Corporation Limited Recommends Dividend for the Financial Year 2024

Indraprastha Medical Corporation Limited to Report Q4, 2024 Results on May 17, 2024

New minor risk - Share price stability

Investor sentiment improves as stock rises 20%

Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Shares Fly 42% But Investors Aren't Buying For Growth

Investor sentiment improves as stock rises 21%

Now 22% overvalued

Third quarter 2024 earnings released: EPS: ₹3.21 (vs ₹2.28 in 3Q 2023)

Why Investors Shouldn't Be Surprised By Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) Low P/E

Indraprastha Medical Corporation Limited to Report Q3, 2024 Results on Feb 06, 2024

Indraprastha Medical Corporation Limited Announces Cessation of Jasmine Shah as Non-Executive Director & Chairman

Investor sentiment improves as stock rises 19%

Second quarter 2024 earnings released: EPS: ₹3.58 (vs ₹2.74 in 2Q 2023)

Why The 29% Return On Capital At Indraprastha Medical (NSE:INDRAMEDCO) Should Have Your Attention

Indraprastha Medical Corporation Limited to Report First Half, 2024 Results on Nov 03, 2023

Now 21% undervalued

We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair

Indraprastha Medical's (NSE:INDRAMEDCO) Dividend Will Be Increased To ₹3.00

Upcoming dividend of ₹3.00 per share at 1.8% yield

Now 22% undervalued

Indraprastha Medical's (NSE:INDRAMEDCO) Upcoming Dividend Will Be Larger Than Last Year's

Investor sentiment improves as stock rises 15%

Indraprastha Medical (NSE:INDRAMEDCO) Is Paying Out A Larger Dividend Than Last Year

First quarter 2024 earnings released: EPS: ₹3.33 (vs ₹2.21 in 1Q 2023)

Indraprastha Medical Corporation Limited, Annual General Meeting, Sep 21, 2023

Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)

Indraprastha Medical Corporation Limited to Report Q1, 2024 Results on Aug 04, 2023

Investor sentiment improves as stock rises 16%

Indraprastha Medical Corporation Limited Recommends Dividend for the Financial Year 2022-23

Full year 2023 earnings released: EPS: ₹9.40 (vs ₹6.39 in FY 2022)

Indraprastha Medical Corporation Limited to Report Q4, 2023 Results on May 23, 2023

Third quarter 2023 earnings released: EPS: ₹2.28 (vs ₹1.74 in 3Q 2022)

Indraprastha Medical Corporation Limited to Report Q3, 2023 Results on Feb 08, 2023

Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation

We Think Indraprastha Medical's (NSE:INDRAMEDCO) Profit Is Only A Baseline For What They Can Achieve

Investor sentiment improved over the past week

Second quarter 2023 earnings released: EPS: ₹2.74 (vs ₹1.32 in 2Q 2022)

Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Indraprastha Medical Corporation Limited to Report Q2, 2023 Results on Nov 04, 2022

Indraprastha Medical Corporation Limited Approves Dividend on Equity Shares for the Financial Year Ended on 31 March, 2022

Upcoming dividend of ₹2.50 per share

Indraprastha Medical Corporation Limited Proposes Dividend for the Fiscal Year 2022

First quarter 2023 earnings released: EPS: ₹2.21 (vs ₹1.68 in 1Q 2022)

Indraprastha Medical Corporation Limited, Annual General Meeting, Sep 23, 2022

Indraprastha Medical Corporation Limited to Report Q1, 2022 Results on Aug 08, 2022

Full year 2022 earnings released: EPS: ₹6.39 (vs ₹0.25 in FY 2021)

Indraprastha Medical Corporation Limited Recommends Dividend for the Financial Year 2021-2022

Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS ₹1.32 (vs ₹0.05 in 2Q 2021)

First quarter 2022 earnings released: EPS ₹1.68 (vs ₹1.35 loss in 1Q 2021)

Full year 2021 earnings released: EPS ₹0.25 (vs ₹4.76 in FY 2020)